SCHEMBL3717253

SCHEMBL3717253

C=CC(=O)NNC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.43
GAA P10253 5/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 1/20 0.40
MIF P14174 1/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 1/20 0.35
DGAT1 O75907 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CTSK P43235 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284141 0.82 APLNR (0.55) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL2926580 0.81 TSHR (0.37) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL11525177 0.77 MEN1 (0.56) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL24514107 0.75 APLNR (0.50) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL4756453 0.75 APLNR (0.51) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL18102802 0.75 TDP1 (0.59) GAAMEN1KMT2AMAPK1LMNA
SCHEMBL12318662 0.75 TDP1 (0.51) GAAMEN1KMT2AMAPK1TSHR
SCHEMBL18756274 0.75 SMN1; SMN2 (0.46) APLNRGAAMEN1KMT2AMAPK1
SCHEMBL25369963 0.74 TSHR (0.53) MAPK1LMNATSHRTDP1ALDH1A1
SCHEMBL27922850 0.73 APLNR (0.42) APLNRGAAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109821-A1 SITU GELLING ZWITTERIONIC HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF UNIV MCMASTER (CA) 2026-04-23 US disclosed
US-12359026-B2 In situ gelling zwitterionic hydrogel compositions, and methods of use thereof MCMASTER UNIVERSITY (CA) 2025-07-15 US disclosed
CN-119838022-A Amatoxin conjugates containing branched linkers 杭州多禧生物科技有限公司 2025-04-18 CN disclosed
CN-113423430-B Amatoxin conjugates containing branched linkers 杭州多禧生物科技有限公司 2024-12-03 CN disclosed
US-20230220166-A1 IN SITU GELLING ZWITTERIONIC HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF MCMASTER UNIVERSITY (CA) 2023-07-13 US disclosed
EP-4153664-A1 IN SITU GELLING ZWITTERIONIC HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF McMaster University (CA) 2023-03-29 EP disclosed
CN-115475249-A Photoresponse carbon monoxide release nanogel and preparation method and application thereof 西北工业大学 2022-12-16 CN disclosed
CN-113423430-A Amanitoxin conjugates containing branched linkers 杭州多禧生物科技有限公司 2021-09-21 CN disclosed
US-20200256860-A1 PRINTABLE HYDROGELS FOR BIOMOLECULE IMMOBILIZATION AND STABILIZATION MCMASTER UNIVERSITY (CA) 2020-08-13 US disclosed
US-20190321512-A1 POLY(OLIGOETHYLENE GLYCOL METHACRYLATE) HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF MCMASTER UNIVERSITY (CA) 2019-10-24 US disclosed
WO-2010098495-A1 IMIDAZOLYLPYRAZINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-09-02 WO disclosed
EP-2181992-A1 POLYCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2010-05-05 EP disclosed
WO-2010025197-A1 PROCESS FOR PREPARING CERTAIN CINNAMIDE COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-04 WO disclosed
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS EISAI R&D MANAGEMENT CO., LTD., (JP) 2009-03-05 US disclosed
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS EISAI R&D MANAGEMENT CO., LTD., (JP) 2009-03-05 US disclosed
US-4451568-A PHOTOPOLYMERIZATION OF A MIXTURE OF ACRYLIC ACID, AMINO ACRYLATE ADHESION PROMOTER AND AN ACRYLATE ABLE TO BIND BIOSUBSTANCES BATTELLE MEMORIAL INSTITUTE (CH) 1984-05-29 US disclosed
WO-1981001412-A1 ADHESIVE COMPOSITION FOR FIXING BIOFUNCTIONAL MOLECULES BATTELLE MEMORIAL INSTITUTE (CH) 1981-05-28 WO disclosed
EP-0029411-A1 Adhesive composition for depositing an adhesive coating able to fix biofunctional molecules, coating obtained and process for its preparation, substrate covered with the coating and its use as a biocatalyst BATTELLE MEMORIAL INSTITUTE (CH) 1981-05-27 EP disclosed
US-4087487-A THREE-DIMENSIONAL DIAZOTIZABLE POLYMER WITH LINEAR POLYMER HAVING BINDING LIGANDS CESKOSLOVENSKA AKADEMIE VED (CS) 1978-05-02 US disclosed
US-3969436-A Carriers for biologically active compounds and methods for the production thereof CESKOSLOVENSKA AKADEMIE VED (CS) 1976-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109821-A1 SITU GELLING ZWITTERIONIC HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF ITGA1, ITGB1, F12 APLNR 3991/4885GAA 4814/4885MEN1 3352/4885
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS APP, BACE1, PSEN1 APLNR 2385/4885GAA 1552/4885MEN1 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.